End Cash: The amount of cash held by the company for the given period.
Takeda Pharmaceutical Co. (TAK) had End Cash of $2.64B for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$18.88B |
|
$14.38B |
|
$77.33B |
|
$96.21B |
|
$16.40B |
|
$26.30B |
|
$33.08B |
|
$49.48B |
|
$46.73B |
|
$-9.36B |
|
$46.73B |
|
3.19B |
|
| Cash Flow Statement Financials | |
$2.72B |
|
$-685.28M |
|
$-3.10B |
|
$3.75B |
|
|
End Cash |
$2.64B |
$-1.11B |
|
$236.84M |
|
$-994.55M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|